Arrhythmias & electrophysiology

C-terminal long-QT type 1 R562S-Kv7.1 variant, the first variant in helix C impairing β-adrenergic response of the slow delayed rectifier K+ channel

EuropacePublished Mechanistic study

Authors' conclusion

R562S-Kv7.1 is the first variant in helix C causing an impaired response of IKs channel to β-adrenergic stimulation, likely due to altered interactions between channel subunits, namely Kv7.1 and KCNE1.

Study context

Population
Four putatively unrelated families in the Czech Republic carrying the LQT1 R562S-Kv7.1 variantfour families
Comparison
R562S-Kv7.1 carriers vs healthy relatives; R562S vs wild-type IKs channels
Methodological detailsClinical and genetic investigation, then functional analysis (whole-cell patch clamp, confocal microscopy, computational simulations) and structural modelling
  • Clinical and genetic investigation, then functional analysis (whole-cell patch clamp, confocal microscopy, computational simulations) and structural modelling

Main finding

As reported in the abstract

  • Significantly prolonged QTc at rest in R562S carriers vs healthy relatives
  • Significantly higher QTc prolongation after exercise in R562S carriers vs healthy relatives
  • R562S channels: preserved membrane localisation
  • R562S channels: significant decrease in IKs with rightward shift of voltage dependence of activation
  • R562S channels: lack of responsiveness to β-adrenergic stimulation, seemingly related to modified KCNE1–Kv7.1 interaction
  • Pro-arrhythmic DADs during β-adrenergic stimulation effectively prevented by mild (5%) ICa inhibition (simulation)

Further findings

Genetic analysis

R562S-Kv7.1 might be a founder LQT1 variant in Central Europe

Original publication

C-terminal long-QT type 1 R562S-Kv7.1 variant, the first variant in helix C impairing β-adrenergic response of the slow delayed rectifier K+ channel. Europace. Published 18 June 2026. doi:10.1093/europace/euag156

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.